Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?

OBJECTIVES: To describe the survival outcome of patients with borderline resectable or locally advanced pancreatic ductal adenocarcinoma (BR/LAPDAC) who have a pathologic complete response (pCR) following neoadjuvant chemoradiation. BACKGROUND: Patients with BR/LA-PDAC are often treated with neoadju...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg
Main Authors: He, Jin, Blair, Alex B., Groot, Vincent P., Javed, Ammar A., Burkhart, Richard A., Gemenetzis, Georgios, Hruban, Ralph H., Waters, Kevin M., Poling, Justin, Zheng, Lei, Laheru, Daniel, Herman, Joseph M., Makary, Martin A., Weiss, Matthew J., Cameron, John L., Wolfgang, Christopher L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178802/
https://ncbi.nlm.nih.gov/pubmed/29334562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000002672
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados